Current Understanding of the Pathophysiology of Allergic Rhinitis

Immunology and Allergy Clinics of North America

Volumn 31, Issue 3, 2011, Pages 433-439

  Rosenwasser, Lanny J ^a,b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergen; Allergic rhinitis; Immune response

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 25; INTERLEUKIN 26; INTERLEUKIN 28; INTERLEUKIN 29; INTERLEUKIN 32; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

ALLERGIC RHINITIS; BASOPHIL; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LANGERHANS CELL; MACROPHAGE; MAST CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ALLERGENS; ANIMALS; ANTIGEN-PRESENTING CELLS; CYTOKINES; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; LEUKOCYTES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 79959975130     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2011.05.009     Document Type: Review

References (30)

1. Young M.C. Rhinitis, sinusitis, and polyposis. Allergy Asthma Proc 1998, 19:211-218.
2. Naclerio R.M. Allergic rhinitis. N Engl J Med 1991, 325:860-869.
3. Frieri M. Inflammatory issues in allergic rhinitis and asthma. Allergy Asthma Proc 2005, 26:163-169.
4. Jordan T.R., Rasp G., Pfrogner E., et al. An approach of immunoneurological aspects in nasal allergic late phase. Allergy Asthma Proc 2005, 26:382.
5. Mygind N., Dahl R. Challenge tests in nose and bronchi: pharmocological modulation of rhinitis and asthma. Clin Exp Allergy 1996, 26:S39-S43.
6. Bisgaard H., Olsson P., Bende M. Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance, and nasas secretion in humans. Clin Allergy 1986, 16:289-297.
7. Donnelly A.L., Glass M., Minkwitz M.C., et al. The leukotriene D4-receptor antagonist, ICI 204, 219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995, 151:1734-1739.
8. Howarth P.H. Mediators of nasal blockage in allergic rhinitis. Allergy 1997, 52:S12-S18.
9. White M. Mediators of inflammation and the inflammatory process. J Allergy Clin Immunol 1999, 103:S378-S381.
10. Steinke J.W., Borish L. Cytokines and chemokines. J Allergy Clin Immunol 2006, 117:S441-S445.
11. Akbari O., Umetsu D.T. Role of regulatory dendritic cells in allergy and asthma. Curr Allergy Asthma Rep 2005, 5:56-61.
12. Chaplin D.D. Overview of the human immune response. J Allergy Clin Immunol 2006, 117:S430-S435.
13. Bellanti J.A. Cytokines and allergic diseases: clinical aspects. Allergy Asthma Pro 1998, 19:337-341.
14. Gigal L.H. Basic science for the clinician 35: CKI, invariant NKT (iNKT) cells, and gamma delta T-cells. J Clin Rheumatol 2005, 11:336-339.
15. Jutel M., Akdis M., Blaser K., et al. Are regulatory T cells the target of venom immunotherapy?. Curr Opin Allergy Clin Immunol 2005, 5:365-369.
16. Chatila T.A. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 2005, 116:949-959.
17. Akbari O., Faul J.L., Hoyte E.G., et al. CD4+ invariant T-cell receptors + natural killer T calls and asthma. N Engl J Med 2006, 345:1117-1129.
18. Kay A.B. Natural killer T cells and asthma. N Engl J Med 2006, 354:1186-1188.
19. Nathan R.A. The burden of allergic rhinitis. Allergy Asthma Proc 2007, 28:3-9.
20. Huang S.H., Frydas S., Kempuraj D., et al. Interleukin-17 and the interleukin-17. Family member network. Allergy Asthma Proc 2004, 25:17-21.
21. Kawaguchi M., Takahashi D., Hizawa N., et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antoganizes wild-type IL-17 activity. J Allergy Clin Immunol 2006, 117:795-801.
22. Schmitz J., Owyang A., Oldham E. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2- associated cytokines. Immunity 2005, 23:479-490.
23. Bilsborough J., Luenh D.Y., Maurer M., et al. IL-31 is associated with cautaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2005, 117:418-425.
24. Finegold I. Allergen immunotherapy: present and future. Allergy Asthma Proc 2007, 28:44-49.
25. Rosenwasser L.J. New insights into the pathophysiology of allergic rhinitis. Allergy Asthma Proc 2007, 28:10-15.
26. Brozek J.L., Bousquet J., Baena-Cagnani C.E., et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010, 126:3.
27. Bousquet J., Khaltaenv N., Cruz A.A., et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)Len and AllerGen). Allergy 2008, 63(Suppl 86):8-160.
28. Ait-Khaled N., Pearce N., Anderson H.R., et al. Global map of the prevalence of snyptoms of rhinoconjuctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase three. Allergy 2009, 64:123-148.
29. Scadding G.K., Durham S.R., Mirakian R., et al. BSACI guidelines for the management of allergic and nonallergic rhinitis. Clin Exp Allergy 2008, 38:19-42.
30. Wallace D.V., Dykewicz M.S., Bernstein D.I., et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008, 122:S1-S84.